
A therapeutic cancer vaccine may be developed from the patient's tumor to help provide the most personalized cancer treatment available. Tumor cells from the Personalized Tumorgraft (cells from the patient's tumor) are genetically modified, then used to stimulate a patient's immune system to recognize and, if possible, attack the patient's cancer cells. Personalized Vaccines are designed to treat cancers that have already occurred. They are intended to delay or stop cancer cell growth; cause tumor shrinkage; prevent cancer from coming back; or eliminate cancer cells that are not killed by other forms of treatment, such as surgery, radiation therapy, or chemotherapy. As part of a comprehensive treatment plan, Personalized Vaccines may have the potential to be a curative therapeutic option.
To learn more about the benefits of Champions' Personalized Oncology Services,
Schedule a Scientific Presentation.
How can Champions’ services benefit my practice?
In addition to the possibility of optimizing personalized cancer treatment options for patients, Champions also offers a liaison to connect physicians to an international network of expert specialists, scientists and researchers. Champions’ services broaden the therapeutic options a physician can provide to the cancer patient and his/her family. Oncology practices that have leveraged Champions services are experiencing new patient referrals from patients who have benefited from the enhanced services provided through Champions.